Ascendis Pharma A/s vs Telix Pharmaceuticals
Ascendis Pharma A/s and Telix Pharmaceuticals are similar in size: $814m and $804m of revenue in their latest fiscal years. Ascendis Pharma A/s grew faster (106.9% against 55.6%). Telix Pharmaceuticals kept more of each dollar of sales as profit: a net margin of -0.9% against -31.7%.
| Latest fiscal year | Ascendis Pharma A/sASND, 2025 | Telix PharmaceuticalsTLX, 2025 |
|---|---|---|
| Revenue | $814m | $804m |
| Revenue growth | 106.9% | 55.6% |
| Net income | −$258m | −$7.1m |
| Operating margin | -18.9% | 3.7% |
| Net margin | -31.7% | -0.9% |
| Return on equity | — | -1.9% |
| Free cash flow | $60.9m | −$43.0m |
| Cash | $723m | $142m |
| Total debt | $956m | $405m |
| Debt to equity | — | 97.5% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $19.7m | — |
| Employees | — | — |
| Market value | $15.18bn | $3.05bn |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 9 buys, 3 sales | 3 buys, 0 sales |